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Summary.-114 biopsy specimens from 70 patients with ovarian carcinoma at all
stages of disease were submitted for assessment of clonogenic capacity in agar.
A highly significant correlation was found between agar clonogenicity and patient
survival after biopsy. However, problems related to inherent tumour heterogeneity,
quality of sample and tissue disaggregation indicate that this technique may have
limited applicability in the routine assessment of patients. Only 41 biopsy specimens
(36%) from 31 patients (44.3%o) complied with the prerequisite criteria for agar
clonogenic assessment, namely: (a) the confirmed presence of malignant cells in the
biopsy, (b) the ability to prepare a single-cell suspension, and (c) adequate viable
cell numbers for assay. Furthermore, although the dominant patterns of agar clono-
genic growth could be identified and correlated with stage of disease, the hetero-
geneity in both initial clonogenic capacity and "self-renewal" capacity assessed by
the ability of primary clones to propagate in liquid culture and reclone in agar was
too inconsistent for the assay to be used as a prognostic index for the individual
patient.
LIQUID-CULTURE techniques have been
used extensively to characterize and prop-
agate tumour cell lines not only for the
study of tumour-cell biology but also in a
search for better diagnostic and prognostic
tools, and for predictive assays which
could be used for the individualization of
tumour therapy. However, because of the
heterogeneity of tumour material, such
studies have met with limited success and
have a number of shortcomings. Tumour
cells are commonly overgrown by normal-
tissue cells at early passages, and normal
cells can undergo spontaneous trans-
formation with acquisition of malignant
characteristics during cell adaptation in
primary culture (Mouriquand et al., 1978).
Although defined growth patterns have
been found in different tumour classes,
they are too inconsistent to permit
differential diagnosis (loachim et al., 1974).
The marker most closely correlated with
tumorigenicity is the ability of neoplastic
cells to grow in agar as anchorage-
independent clones (Barrett & T'so, 1978;
Shin et al., 1975). Exploiting this property,
clonal agar assays for human tumour
stem cells have been developed (Courtenay
& Mills, 1978; Hamburger & Salmon, 1977)
and appear to present investigators with
a powerful tool for the analysis of the
factors influencing the proliferation,
maturation and differentiation of tumour-
cell populations. Attempts have also been
made to use these assays predictively for
the screening of chemotherapeutic agents
(Alberts et al., 1980; Salmon et al., 1978)
but the limitations of the agar clonogenicT. BERTONCELLO, ET AL.
assay, when applied to primary biopsy
material, remain ill defined, and the
assumption that true human tumour
stem cells are being cloned has not been
adequately validated.
The correlation between agar clonogenic
capacity and tumorigenicity has been
derived mainly from experiments with
relatively homogeneous, usually undiffer-
entiated cell lines or tumours in highly
inbred animal strains, and relatively little
is known about the acquisition of this
property or its alteration with tumour
progression. In applying the assay to
primary human tumour biopsy specimens
much greater variability might be encoun-
tered; in the light of the known hetero-
geneity of tumours (Mihich et al., 1979)
the specimen may not be representative
ofthetumourasawhole, andthe extremely
slow doubling time of many tumours
(Tubiana & Malaise, 1976) may enable
expression of clonogenic capacity by only
that sub-population of stem cells which is
capable of the 5-6 doublings required to
form a colony within the 21 days of the
assay. Such possibilities have significant
bearing on the interpretation of assay
results.
In an attempt to answer some of these
questions ovarian tumour-biopsy speci-
mens were screened for cells clonogenic in
agar. This paper describes the correlation
of growth in agar culture with basic
clinical data and discusses the limitations
of the agar-culture assay for the assess-
ment of human tumour stem cells in the
light ofthis study.
MATERIAL AND METHODS
Collection of biop8y material.-Biopsy mat-
erial was collected from patients with ovarian
carcinoma undergoing laparotomy or follow-
up laparoscopy. Representative sections of
solid tumour specimens were placed in bal-
anced salt solution (BSS) and effusions were
collected into sterile 500ml bottles containing
15,000u of preservative-free heparin. On
arrival at the laboratory a portion of the
biopsy specimen was placed in neutral
formalin for histology and aliquots of ascitic
fluid were set aside for cytology in order to
confirm the presence of malignant cells.
Preparation and disaggregation of tumour
specimens for clonal agar culture.-Solid
tumour specimens were finely minced with
scissors and suspended in complete medium
containing 0.1% collagenase (Sigma, Type 1)
and incubated overnight at 37°C in an atmo-
sphere of 7% 02, 10% CO2 and 83% N2.
The suspension was then gently pipetted to
break up tissue fragments and centrifuged,
and the cell pellet washed twice in BSS to
remove residual collagenase. Any remaining
aggregates and debris were removed by
layering the cell suspension over foetal calf
serum (FCS) for 10 min. Aggregates and
undigested material sedimented through the
serum and the resulting supernatant cell
suspension was collected for culture.
Samples of ascitic fluid were centrifuged
and the cell pellet was washed twice in BSS
and resuspended by gentle pipetting. If
ascitic effusions yielded a cell pellet mostly
composed of erythrocytes, the cell pellet was
resuspended in BSS and layered over Ficoll/
Hypaque (1 079 g/cm3) and centrifuged for
20 min at 2000 g. The cell band at the inter-
face was then collected and the cells were
washed as described above. The cell suspen-
sion was examined microscopically for aggre-
gates. In some cases aggregation was marked
writh few single cells present and most aggre-
gates containing > 100 cells. In these cases
the cell suspension was incubated overnight
in complete medium containing 0.1% col-
lagenase in an attempt to disperse the cells.
As agar culture is a clonal assay intended
to quantify tumour stem cells, great emphasis
was placed on the need for a single-cell
suspension. Cell counts were made using a
haemacytometer, and the proportion ofviable
cells was determined by their ability to
exclude nigrosin. In reality, true single-cell
suspensions were difficult to achieve. All
samples which contained aggregates > 3-5
cells were excluded from the study.
Culture methods.-The alpha modification
of Eagle's medium (Flow) supplemented with
4mM L-glutamine, MEM vitamins, 20 mg/l
gentamycin sulphate (Roussel) and 20%
FCS (Flow) was used throughout this study.
The osmolarity of all media was routinely
monitored (Fiske 08220 VAL freezing-point-
depression osmometer) and maintained at
310 mOsmol.
Clonal agar culture was performed in a
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double-layer agar system using a modification
of the method routinely used for the growth
of marrow cell colonies in this laboratory and
extensively described elsewhere (Bradley
et al., 1978). Briefly, a Iml underlay con-
taining culture medium with a final agar
(Difco, Bacto-agar) concentration of 0.5%o
was dispensed in 35mm plastic Petri dishes
(Kayline). Viable nucleated cells were rout-
inely seeded in 5 replicate 0-5ml overlays
(2 x 104/dish) containing medium with a final
agar concentration of0.3%. No attempt was
made to differentiate between normal and
neoplastic cells. Factors to be tested for
growth-promoting properties were included
in the underlay. Dishes were incubated for
21 days in a humidified atmosphere of 700
02, 10% CO2 and 83% N2 in sealed plastic
boxes. A low, oxygen tension in the gas
mixture is used routinely in this laboratory in
preference to conventional gas mixtures of
CO2 in air, as it has been our experience that
cell growth in both agar and liquid cultures is
markedly improved under low oxygen tension
(Bradley et al., 1978).
Colonies of at least 40 cells were counted
and sized with a calibrated eye-piece grid
using an Olympus SZ III dissecting binocular
microscope with transmitted indirect lighting
at x 20 magnification. Where necessary, more
detailed inspection of suspected colonies was
made using an inverted microscope at x 100
to x 320 magnification.
Establishment and recloning of putative
tumour-cell lines.-In order to assess the self-
renewal capacity of putative tumour stem
cells, the recloning capacity of our agar
colonies was measured. Twenty colonies were
plucked randomly from the original agar
cultures using fine-tipped micro-pipettes. The
pooled colonies were dispersed by gentle
pipetting, and seeded in a 25cm2 flask
(Costar) in 5 ml of medium. These liquid
cultures were incubated at 37°C with weekly
refeeding. Cultures exhibiting growth were
harvested using 0.01% Pronase (Calbiochem)
in phosphate-buffered saline (PBS) contain-
ing0*54 mm EDTA, when therewereadequate
cell numbers to permit recloning. The cell
suspension was centrifuged and the cell
pellet was washed twice in BSS before
recloning in agar at cell densities ranging
from 103 to 2 x 104 cells as described above.
The remaining cells were reseeded and
passaged in liquid culture with weekly re-
feeding and split at a 1:4 ratio at confluency.
Rat erythrocyte suspensions -Blood was
obtained from rats by cardiac puncture. The
plasma and buffy coat were removed after
centrifugation and the packed erythrocytes
were washed x 5 in isotonic NaCl and centri-
fuged. Three volumes of BSS were added to
one volume of packed erythrocytes and the
resulting 1:4 RBC suspension was heated at
44°C for 1 h to destroy residual nucleated
cells. Erythrocyte suspensions were stored at
4°C and discarded after 10 days.
RESULTS
The quality and heterogeneity of biopsy
specimens was a major obstacle to the
routine application of the clonal agar
assay to the assessment of the clonogenic
capacity of ovarian tumours. In order to
make meaningful conclusions about the
clonogenic capacity of a tumour popula-
tion it was decided that certain pre-
requisites should be met in both sampling
and preparation of the tumour material
for agar culture. These were: (a) the con-
firmation of the presence of malignant
cells in the biopsy sample by cytological
or histological examination; (b) the ability
to prepare a single-cell suspension by
mechanical or enzymic dispersion; and,
(c) the availability of enough viable cells
to perform the assay.
Of 114 specimens collected from 70
patients at all stages of disease, only 41
specimens from 31 patients met the above
criteria. The grounds for rejection of the
73 specimens not amenable to clonogenic
assessment are listed in Table I. A signi-
ficant number ofascitic effusions contained
too few cells for a reliable assay, and low
viability with consequent low cellularity
was a problem frequently encountered
with solid tumour specimens. A number of
specimens containing large cellular aggre-
gates which were resistant to mechanical
or enzymic dispersion, were also excluded
from the study. Twelve specimens had
apparently normal histology or cytology,
and 3 specimens -were indefinite.
Very rigid criteria were adopted for the
assessment of agar clonogenic capacity.
Growth was deemed to have occurred
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TABLE I.-The quality of ovarian tumour biopsy specimens collected for assay of agar
clonogenicity, listing the principal criteria for rejection from the study
Lov cellularity
Lowv viability
Aggregation
Contaminatioln
Tumour negative
cytology/histology
Indlefinite cytology/
hlistology
Insufficient material
Amenable to agar culture
Total
No. Total
patients* biopsies*
18 22
12 14
9 12
.3 3
10 12
2 3
6
31
70
7
41
114
Solid Ascitic
specimens effusions
3
12 1w
3
1
(
5
16
41
19
2
11
0
11
25
73
* Alultiple specimens from some patients.
only if clones of healthy, light-refracting
cells could be observed at the end of the
incubation period. Colonies varied greatly
inappearance fromtightlypackedspherical
balls of cells to highly differentiated struc-
tures, such as the hollow cystic colonies
which were grown from an ascitic effusion
taken from a patient with clear-cell
carcinoma (Fig. A). Cell aggregates of
< 40 cells (Fig. B) were scored as clusters.
Another class of aggregate, composed of
a small but indeterminate number of cells
with evidence ofnecrosis and degenerating
giant cells (Fig. C) was not scored, as it
was felt that they were not true stem-cell
clones, but abortive colonies of non-
surviving cells.
Since the agar-culture assay is a func-
tional assay, the assessment ofgrowth was
based primarily on the quality of the
colonies rather than the absolute plating
efficiency, though these properties are
closely correlated. Three growth patterns
could be defined: (a) NG (no growth)
complete absence of clusters or colonies,
or dishes with only abortive clones; (b)
Type I (limited growth) cluster formation,
or clusters and colonies of < 150 ,tm
diameter, and generally showing evidence
of deterioration (cloning efficiency 0-06 +
0 03oo); (c) Type II (good growth) colony
formation with all colonies being of good
quality and some colonies > 250 um
diameter (cloning efficiency 0 31 + 0-17O%).
In several experiments, a variety of
factors, either alone or in various com-
binations, were included in the culture
medium in an attempt to improve the
plating efficiency and quality of colony
growth. These factors included insulin,
transferrin, gonadotrophins, oestradiol,
hydrocortisone, pituitary extracts, human
milk, epidermal growth factor, fibronectin,
glutathione, phorbols, human and mouse
spleen-conditioned media and erythrocyte
suspensions. With the exception of the
erythrocyte suspensions no factor or
combination of factors improved the
quality of the growth in agar. However,
although RBC invariably improved the
quality of colonies, and once enabled the
detection of clonal growth in two speci-
mens which did not grow without them,
the effect on cloning efficiency was vari-
able (Table II) cloning efficiency being
enhanced by RBC in 9/15 specimens, and
decreased in 4/15.
The inclusion of a fibroblast feeder
layer, or the replacement of agar
with collagen, methyl-cellulose or agarose,
also failed to improve the cloning effi-
ciency.
Basic clinical data together with culture
outcome for the 41 specimens amenable
to clonal agar culture is provided in Table
II. Of the 41 biopsy specimens from 31
patients included in the study, 23 speci-
mens (56a1%O) from 18 patients (58 1%O)
exhibited some degree ofgrowth. Although
the proportion of specimens capable of
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clonogenic growth compares favourably Biopsy material was obtained from
with that of previously published studies, patients with a diversity of histological
this represents only 20.2% of the initial tumour types and clinical histories (Table
114 specimens submitted for assessment. II). It will be appreciated that this diver-
sity precludes any meaningful statistical
@s. X *;** t _ evaluation of the influence of tumour
type or previous therapy on clonogenic
capacity of tumour biopsy specimens.
However, there is a highly significant
correlation between agar clonogenic capa-
city and survival of patients after biopsy,
when the data is subjected to Kaplan-
Meier survival analysis (Table III)
\ |9>yi(Logrank test, x2 = 12-2 on 2 d.f., P < 001).
Type II growth in agar is therefore corre-
. lated with a poor prognosis. All patients
whose tumours showed Type II growth
in agar died with a short mean survival
time (74 days). Type II biopsies had a
W F _ ai X X b w higher cloning efficiency than Type I
growth. When data collation for this
A.>'>;t'>>Et: fg)8;f;i;t iistudy terminated, half of the patients
<W;;-Nri associated with Type I growth or no
growth had also died, but with longer
4 ' g'i., * 4 survival times: 103 days and 203 days
respectively.
A ^; '^ > t<So t t _ Although the prognosis for patients
B z@tw -t #v; 1 * * _ whose tumours exhibited Type II growth
WSizs; X iF # * * d in agar is poor, not all samples from
grlt a #terminal patients exhibited growth. Biop-
sies from 4 patients with terminal disease
F4; W4ll _ z _ exhibited either no growth (pts 30 and 21)
or Type I growth (pts 1 and 18) as little
as 3 weeks before death. Furthermore,
8 patients included in this study provided
multiple samples, either on the same day
or during the course of disease. Of the 3
patients providing multiple samples on
the one occasion (pts 18, 28 and 30)
patient 28 gave different results for the
2 specimens. Of the remaining 5 patients
2 (pts 5 and 19) exhibited the same culture
outcome on each occasion and 2 (pts 4 and
c
FIGURE. Morphology of agar colonies of
human ovarian-tumour cells photographed
in 8itu in agar at the 21st day ofincubation,
(phase contrast). (A) Hollow cystic colony
(x 90) grown from an effusion of a patient
with clear-cell carcinoma; (B) cluster of
ovarian tumour cells ( x 29); (C) Abortive
clone of ovarian tumour cells ( x 58) con-
taining giant cells and degenerating.
807I. BERTONCELLO ET AL.
TABLE II.-Correlation of clinical data with clonogenic capacity
Pt
no. Diagnosis
I Pap serous cystadeno
2 Poorly diff adenoca
3 Mucinous adenoca
4a Pap serous cystadeno
4b Pap serous cystadeno
5a Pap serous cystadeno
5b Pap serous cystadeno
6 Pap serous cystadeno
7 Pap serous cystadeno
8 Undifferentiated Ca
9 Serous cystadenoca
1Oa Endometrioid Ca
lOb Endometrioid Ca
11 Endometrioid Ca
12 Pap serous cystadeno
13 Pap serous cystadeno
14a Clear cell Ca
14b Clear cell Ca
14c Clear cell Ca
14d Clear cell Ca
15 Clear cell Ca
16 History unavailable,
17 Clear cell Ca
18a Unclassified
18b Unclassified
19a Serous cystadeno
19b Serous cystadeno
20 Serous cystadeno
21 Serous cystadeno
22 Granulosa cell Ca
23 History unavailable
24 Pap serous cystadeno
25 Unclassified
26 Pap serous adenoca
27 Serous cystadenoca
28a Unclassified
28b Unclassified
29 Unclassified
30a Undifferentiated Ca
30b Undifferentiated Ca
31 Serous cystadenoca
Stage
III:R
III:UP
III:R
III:PD
III:PD
IV:UP
IV:UP
IV:P
III:UP
III:UP
II:UP
III:R
ITI:R
II:R
PD
IV:R
IV:R
IV:R
IV:R
I:R
II:UP
p
p
R
R
III:R
III:PD
III:R
III:UP
UP
III:R
III:UP
III:UP
III:UP
III:UP
IV:UP
TV:UP
III:PD
Therapy
at
biopsy
Nil
Nil
CT
CT
Nil
Nil
Nil
CT
Nil
Nil
Nil
Nil
Nil
Nil
Nil
CT
CT
Nil
Nil
Nil
Nil
Nil
CT
CT
Nil
Nil
CT
Nil
Nil
Nil
Nil
Nil
Nil
Nil
Nil
Nil
CT
Type
of
biopsy
A
A
A
A
A
A
A
A
A
A
S
.S
A
s
A
A
A
A
S cs
S
S
S
S
S
A
A
A
?
A
S
A
S
A
S
A
A
S
A
Days from
biopsy to
A
last death
follow-up
20
623
83
200
80
160
139 -
_ 00
406
523
349
451
36
11
288
274
25
226
226
222
12
UV7
191
349
256
24
5
191
171
150
8
261
22
22
23
22
224
263
1
PE (%)
-RBC +RBC
0-01 0-002
NS NS
NS NS
0-37 0-50
0 0
0-018 0-033
NS NS
0-73 0-60
0-001 0-003
0 0
0 0
0 0
0-031 0-047
0-089 0-034
0-10 -
0 0
0-71 0-90
0-011 0-021
0-058 0-119
0 0
0 0
0-002 0-002
0 0
0-007 0-003
0-011 NP
0 0
0 0
0 0
0 0
0 0
NS NS
NS NS
0-01 NP
0 0
0 0
0 0
0-02 0-02
0 0
0 0-01
0 0-02
0 0
Abbreviations: R, recurrence. PD, persistent disease. UP, untreated primary. P, primary. CT, chemo-
therapy. A, ascitic effusion. S, solid biopsv. F/up, followup. NS, not scored. NP, not plated.
TABLE III.-Correlation between quality of growth in agar
following initial biopsy
Quality
Number of deaths
Post-biopsy survival
(days)
PE of biopsies from
deceased patients
-RBC
+RBC
NG Type I
8/14 5/11
202-5+41-6 103-2+39-4
0 0-10+0-09
0 0-13+0-12
and survival of patients
Type II
4/4
74-0+45-1
0-38+0-20
0-39+0-22
Type
of
growth
I
I
I
NG
I
I
Ii
I
NG
NG
NG
I
II
I
NG
II
I
I
NG
NG
I
NG
I
I
NG
NG
NG
NG
NG
I
I
I
NG
NG
NG
I
NG
II
II
NG
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TABLE IV.-Abilityoffirs
ies to produce clonogen
1Patient
11
12
14
30
EH
EV
Initial
cloning
Type II
Type I
Type II
Type II
Type II
Type I
Li
cu
* Agar clonogenic lines esti
4) achieved a poorer res
sample taken than in the
In an attempt to m
renewal capacity of tumo
recloning capacity of thE
agar clones was assessed
Material and Methods.
attempts are shown in
growth patterns were c
propagation in liquid cult
tion in liquid culture, wi
agar; (c) propagation ii
with ability to reclone i:
the establishment ofclonc
DISCUSSIO:
The ability of ovarian I
in agar has been dem
number of occasions (Alb
Courtenay et al., 1978;
1978; Salmon et al., 1978
purpose of this study to c
limitations of the techniq
its application to the roi
of the clonogenic capa
tumours.
Technical difficulties
inherent heterogeneity of
et al., 1979) and the ass(
of tissue sampling and
agar culture are a major
routine application of th4
only precluded the asse
clonogenic capacity of 73
from 39 patients (55.70/
(Table I) but were en
greater or lesser degree in
assayed.
t-generationcolon- Variability in quality and quantity of
ic cells in agar biopsy material and in tumour-cell con-
quidl tent of biopsy specimens, also noted by
ilture Recloning other workers (Buick et al., 1980; Von
Hoff et al., 1980) reflect the nature of the
+ NG tumour, and are beyond the control ofthe
+- Type II* investigator. Perfect single-cell suspen-
+ Type II* sions are also difficult to achieve (Laboisse
- - et al., 1981; Rupniak & Hill, 1980) and
ablisle(e. the possibility of some growth from
aggregates cannot be excluded. These
in the last problems compromise both the selectivity ponse of the assay for the growth of anchorage- first. independent cells and the determination
ieasure the self- eaure sthe elf- t of the absolute cloning efficiency of ur stemcelsthe individual specimens.
efirst-generation*
as described in Quality of growth in agar is another
The results of 6 parameter of the assay system which has
Taerbl IV. Thre received little attention. Although a
tabled(V ) Then highly significant correlation was found b between agar clonogenic capacity and the
ure; (b) propaga- survival of patients after biopsy (Table .th no cloning in III) supporting previous observations on
n liquid culture human gastrointestinal carcinomas
n agar, enabling (Laboisse et al., 1981) and neuroblastomas )genic cell.lines. (Von Hoff et al., 1980) the considerable
variability encountered in the size, appear-
N ance and replicative capacity of the
colonies indicate clonal heterogeneity
tumours to clone among and within tumours.
tonstrated on a Aggregates exhibiting extensive necrosis
)erts et al., 1980; and containing giant cells were not scored
Iamburger et al., as colonies, as it was felt that they
3) but it was the represented abortive clones composed of
Iraw attention to cells with limited replicative life-span.
ue which impede This phenomenon has been extensively
utine assessment described in liquid cultures (Puck &
bcity of human Marcus, 1956; Tolmach & Marcus, 1960)
and is supported by the observation of
related to the Danes (1980) that similar small anchorage-
tumours (Mihich independent clones comprised in viable
)ciated problems cells. Alternatively, these aggregates may
preparation for be true clones growing under nutritional
obstacle to the deprivation, or deprivation of cell-cell
e assay, and not interaction (Buick et al., 1980).
.ssment of agar A tumour stem cell, by definition, would
specimens (64%) be expected to have extensive and
0I) in this study measurable self-renewal capacity. Carney
countered to a et al. (1980) and Pavelic et al. (1981) were
all the specimens unable to show that colonies transferred
from semi-solid cultures exhibited con-
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tinuous replication in liquid culture,
though cell suspensions from pools of
large colonies were able to induce tumour
growth in nude mice (Pavelic et al., 1980).
Our own attempts at propagating clones
in agar culture also had limited success
(Table IV). When large clones were
plucked from agar, pooled, and resus-
pended in liquid culture, growth was
achieved on 3/6 occasions, and only 2
of these liquid cultures showed clonogenic
capacity in agar.
Tubiana & Malaise (1976) reviewing the
the prognostic and therapeutic implica-
tions of tumour-cell kinetics, point out
that, although there is no simple pro-
portionality, there is a broad relation-
ship between histological differentiation,
growth rate and prognosis. Therefore,
Type II growth in agar, which is corre-
lated with poor prognosis (Table III) may
be a reflection of shorter doubling times
of the tumour population, permitting
expression of this property during the
assay. Alternatively, agar clonogenic capa-
city may only be acquired as a late
phenotypic marker of tumorigenicity, as
suggested by a number of studies (Barrett
& T'so, 1978; Hard et al., 1977; Neugut &
Weinstein, 1979; Roscoe et al., 1980).
Both explanations are consistent with
Nowell's (1976) hypothesis of the clonal
evolution of tumour-cell populations,
which envisages tumour progression occur-
ring by the sequential selection ofincreas-
inglygenetically and biologicallyabnormal
sublines with the potential for continued
variation. Therefore, agar clonogenic capa-
city may not be a totally reliable index
of the whole spectrum of tumorigenic
stem cells at the various stages ofdisease.
In summary, clonal agar assays for the
assessment of individual tumour biopsy
specimens have significant limitations.
Only 41/114 biopsies were suitable for
agar culture, and of these only 23 were
able to grow in agar, with only 5 showing
Type II growth. The assay therefore
appears to be of limited applicability to
the individualization of chemotherapeutic
regimes. The quality of growth which
would enable chemosensitivity to be
assessed most precisely (Type II growth)
is generally characteristic of patients in
very advanced stages of disease, when
such an assessment is of least value.
Evidence of clonal heterogeneity has not
only been found in this study, but has
also been demonstrated by MacKintosh
et al. (1981) who showed that 5 cell lines
derived from individual agar clones grown
from a single human ovarian tumour
specimen, exhibited differing patterns of
growth, morphology and drug sensitivity
in culture.
In the light of these reservations and
those of other workers (Rupniak & Hill,
1980; Selby & Raghavan, 1981) further
basic research aimed at the optimization
of this assay system is required. These
results also highlight the need for a
reliable animal model for the study of
tumour progression and of the develop-
ment of clonal heterogeneity within
tumours.
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NOTE ADDED IN PROOF
Our attention has been drawn to a recent publica-
tion supporting our findings that significant clonal
heterogeneity exists, both in initial cloning capacity
and in self-renewal of primary clones. BUICK, R. N.
& MACKILLOP, W. J. (1981, Measurement of self-
renewal in culture of clonogenic cells from human
ovarian carcinoma. Br. J. Cancer, 44, 394) have
demonstrated a marked patient-to-patient variation
in relf-renewal capacity of clonogenic cells, and that
not all primary clonogenic cells could undergo self-
renewal during clonal suspension in culture.
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